Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
877.79
-31.53 (-3.47%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
99
100
Next >
Understanding Eli Lilly and Co's Position In Pharmaceuticals Industry Compared To Competitors
April 05, 2024
Via
Benzinga
Eli Lilly and Co Options Trading: A Deep Dive into Market Sentiment
April 05, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
April 04, 2024
Via
Benzinga
Spring 2024 Snapshot Of The S&P 500's Market Cap
April 04, 2024
The first quarter of 2024 has come and gone. Before it did, the S&P 500 clocked a new record high of 5,254.35.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
3 Growth Stocks with Even Greater Potential Than the Magnificent 7
April 04, 2024
Here are three Magnificent 7 contenders growth investors shouldn't be sleeping on right now, given their long-term potential.
Via
InvestorPlace
Unpacking the Latest Options Trading Trends in Eli Lilly and Co
April 03, 2024
Via
Benzinga
What Analysts Are Saying About Eli Lilly and Co Stock
April 01, 2024
Via
Benzinga
7 A-Rated Stocks to Buy in April
April 04, 2024
These A-rated stocks to buy for April will help you forget about the pain of tax season. Instead, enjoy the profits from these top stocks.
Via
InvestorPlace
Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market?
April 04, 2024
Viking shares have soared recently on optimism about its program.
Via
The Motley Fool
Why Eli Lilly Stock Topped the Market Today
April 03, 2024
One analyst following the company believes it could grow its revenue meaningfully this year.
Via
The Motley Fool
The 3 Best Healthcare Stocks to Buy in April 2024
April 03, 2024
The healthcare industry is not going to stop growing anytime soon. These are the best healthcare stocks to buy in April.
Via
InvestorPlace
Eli Lilly Struggles To Keep Pace With Mounjaro, Zepbound Demand: 'Currently Unavailable' On Amazon Pharmacy
April 03, 2024
Eli Lilly's stock skyrockets but now trading sideways as demand for weight-loss drugs outpaces supply. Availability issues lead to FDA shortages.
Via
Benzinga
Exposures
Product Safety
Novo Nordisk's Popular Diabetes Drug Ozempic Starter Kits Face Extended Shortages in Germany, Faces Biosimilar Threat In China
April 03, 2024
Novo Nordisk warns of Ozempic starter kit scarcity in Germany amid ongoing supply challenges in Europe. Restrictions on off-label use emphasized, with intermittent shortages expected in 2024....
Via
Benzinga
Exposures
Product Safety
Viking Therapeutics Surges Sentiment for Triple Threat GLP-1Pill
April 03, 2024
Viking Therapeutics is preparing to be the next entry into the GLP-1 Market, and VKTX stock is soaring as analysts start to bid the stock higher
Via
MarketBeat
Exposures
Product Safety
Costco Long Known For Rotisserie Chicken And Hot Dogs Counters Junk Food With Weight Loss Plan To Help You Shed Those Extras
April 03, 2024
Costco's new weight loss initiative, in partnership with Sesame, a healthcare marketplace, will offer members a three-month clinical consultation and other services for $179.
Via
Benzinga
5 Healthcare Stocks to Buy for 2024
April 02, 2024
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race
April 02, 2024
AstraZeneca's CEO Pascal Soriot celebrates hitting a $45 billion sales target set a decade ago despite initial skepticism. Investor confidence remains a challenge amid stagnant shares and concerns over...
Via
Benzinga
Citi Monitors Competitive Threats To Eli Lilly, Says It Is Positioned To Maintain Leadership And Expand
April 02, 2024
Citi Research raises price target for Eli Lilly, citing improved risk-adjusted sales outlook for GLP-1 agonist orforglipron. With Phase 3 trials ongoing since 2023, concerns about liver toxicity...
Via
Benzinga
Gene Therapy Side Effects: Verve Therapeutics Halts Enrollment Of Lead Gene Therapy Trial In Patients With Bad Cholesterol
April 02, 2024
Verve Therapeutics' latest update on the Heart-1 Phase 1b trial of VERVE-101. Explore VERVE-102's development and regulatory clearances for the Heart-2 clinical trial, offering hope for patients with...
Via
Benzinga
Merger Mania: 3 Potential Takeover Targets to Watch for Lucrative Buyouts
April 02, 2024
With interest rates poised to fall, acquisitions will become more numerous. Here are three potential takeover targets.
Via
InvestorPlace
Eli Lilly Stock Navigates Weight-Loss Drug Competition With Technical Resilience
April 02, 2024
Eli Lilly's stock has performed well over the past year, gaining 116.84%. So far in 2024, the stock has returned 29.45% to investors.
Via
Benzinga
Meta Platforms, AMD Lead 10 Stocks Showing This Bullish Action
April 02, 2024
Several leading stocks are finding support around the 10-week line, creating potential buying opportunities.
Via
Investor's Business Daily
DexCom Stock Gains from GLP-1 Diabetic Users
April 02, 2024
DexCom Inc. (NASDAQ: DXCM) is a leading medical device company in the medical sector that specializes in continuous glucose monitoring (CGM) systems. People
Via
MarketBeat
Buy Amazon Stock Now for Continued Growth and Diversification
April 02, 2024
Year to date, Amazon's share price is up 20%, nearly double the 11% gain in the benchmark S&P 500 index. Over the last 12 months, Amazon stock has gained 75%.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Could Viking Therapeutics Stock Be a Millionaire Maker?
April 02, 2024
There is a plausible path for this biotech stock to make some investors millionaires.
Via
The Motley Fool
Is It Too Late to Buy Eli Lilly Stock?
April 02, 2024
There's more to the Lilly story than just excellence in one treatment area.
Via
The Motley Fool
Top Stock Reports For Apple, Nvidia & Eli Lilly
April 01, 2024
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc., NVIDIA Corporation, and Eli Lilly and Company.
Via
Talk Markets
Missed the "Magnificent Seven"? Try Buying These 3 Forever Stocks Instead
April 01, 2024
All three companies have very long runways for growth ahead.
Via
The Motley Fool
Meet The "Magnificent Seven" of Healthcare Stocks
April 01, 2024
The tech sector doesn't have a monopoly on magnificent corporations.
Via
The Motley Fool
2 Top Biotech Buyout Candidates
March 31, 2024
Investors who are adventurous, have a high-risk tolerance, and are home run hitters may opt for biotech stocks. Investors in this group may want to hone in on stocks that have the potential to be...
Via
Talk Markets
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.